MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,303,950 | -67.5% | 630,395 | -54.4% | 0.00% | -66.7% |
| Q2 2023 | $19,372,608 | 0.0% | 1,382,770 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $19,372,608 | -100.0% | 1,382,770 | -35.8% | 0.01% | -71.0% |
| Q3 2022 | $54,963,564,000 | -21.5% | 2,152,901 | -12.7% | 0.03% | -16.2% |
| Q2 2022 | $70,056,162,000 | -27.4% | 2,465,898 | -9.9% | 0.04% | -9.8% |
| Q1 2022 | $96,477,700,000 | -49.0% | 2,735,404 | -39.4% | 0.04% | -43.1% |
| Q4 2021 | $189,224,593,000 | -6.7% | 4,516,100 | +9.3% | 0.07% | -14.3% |
| Q3 2021 | $202,856,766,000 | +37.4% | 4,133,186 | +16.8% | 0.08% | +33.3% |
| Q2 2021 | $147,671,578,000 | +25.9% | 3,538,739 | +7.6% | 0.06% | +21.2% |
| Q1 2021 | $117,253,569,000 | +11.1% | 3,289,943 | -12.6% | 0.05% | +6.1% |
| Q4 2020 | $105,552,484,000 | – | 3,763,012 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $1,064,105,000 | 26.99% |
| Ghisallo Capital Management LLC | 1,250,000 | $61,350,000 | 2.33% |
| Beck Bode, LLC | 160,064 | $7,856,000 | 2.19% |
| Select Equity Group, L.P. | 12,122,011 | $594,948,300,000 | 2.00% |
| Pinz Capital Management, LP | 83,603 | $4,103,000 | 1.86% |
| Monashee Investment Management LLC | 185,000 | $9,080,000 | 1.68% |
| Ownership Capital B.V. | 2,717,559 | $133,378,000 | 1.51% |
| Eversept Partners, LP | 327,810 | $16,088,915 | 1.12% |
| Parkman Healthcare Partners LLC | 90,000 | $4,417,000 | 1.12% |
| Connacht Asset Management LP | 28,569 | $1,402,000 | 0.91% |